2026-2034年全球神經診斷和監測設備市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，神經診斷和監測設備的市場規模將從 2025 年的 87.7 億美元達到 175.5 億美元，並預計從 2026 年到 2034 年將以 8.01% 的複合年成長率成長。

由於癲癇、帕金森氏症、阿茲海默症和中風等神經系統疾病的盛行率不斷上升，全球神經診斷和監測設備市場正經歷顯著成長。人們對早期診斷和持續監測重要性的認知不斷提高，推動了對先進影像和神經監測系統的需求。腦電圖 (EEG)、肌電圖 (EMG) 和腦部影像設備的技術進步正在提高診斷準確性和改善患者預後。全球醫療保健基礎設施的不斷改進和老年人口的成長進一步加速了市場成長。

關鍵成長要素包括醫療費用支出增加、微創診斷工具的普及以及人工智慧分析技術在神經系統評估中的應用。醫院和專科診所正在投資攜帶式和穿戴式監測設備，以即時追蹤患者病情。此外，旨在加深我們對神經退化性疾病理解的研究舉措也推動了對先進診斷平台的需求。已開發地區的政府資助和優惠的還款政策也顯著促進了市場成長。

展望未來，數位健康技術和遠端監測解決方案的持續創新有望推動市場發展。緊湊型無線神經診斷系統的開發將有助於新興市場更好地獲取相關服務。遠端醫療的普及和個人化治療方案的進步將進一步提升市場需求。隨著全球神經系統疾病發病率的持續上升，對精準高效的診斷和監測設備的需求預計將支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球神經學診斷與監測設備市場：依設備類型分類

• 市場分析、洞察與預測
• 腦電圖（EEG）系統
• 磁振造影造影（MRI）系統
• 電腦斷層掃描器（CT掃描儀）
• 正子斷層掃描（PET）系統
• 超音波影像設備
• 其他

第5章 全球神經學診斷與監測設備市場：依適應症分類

• 市場分析、洞察與預測
• 神經退化性疾病
• 癲癇
• 中風
• 其他

第6章 全球神經診斷與監測設備市場：依最終使用者分類

• 市場分析、洞察與預測
• 醫院和外科中心
• 神經病學中心
• 門診部
• 診斷檢查室和診斷影像中心
• 研究機構和學術機構

第7章 全球神經學診斷與監測設備市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • GE Healthcare
  • Neurosoft
  • Canon Medical Systems Corporation（Canon Inc.）
  • Fujifilm Holding Corporation
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Shimadzu Corporation
  • United Imaging Healthcare Co. Ltd
  • Hologic Inc
  • Esaote SpA

The Neurology Diagnostic and Monitoring Devices Market size is expected to reach USD 17.55 Billion in 2034 from USD 8.77 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The Global Neurology Diagnostic and Monitoring Devices Market is experiencing strong growth due to the rising prevalence of neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and stroke. Increasing awareness regarding early diagnosis and continuous monitoring has driven demand for advanced imaging and neuro-monitoring systems. Technological advancements in EEG, EMG, and brain imaging devices are improving diagnostic accuracy and patient outcomes. Expanding healthcare infrastructure and growing geriatric populations worldwide are further accelerating market expansion.

Key growth drivers include increasing healthcare expenditure, adoption of minimally invasive diagnostic tools, and the integration of AI-based analytics in neurological assessments. Hospitals and specialty clinics are investing in portable and wearable monitoring devices for real-time patient tracking. Additionally, research initiatives focused on understanding neurodegenerative diseases are supporting demand for advanced diagnostic platforms. Government funding and favorable reimbursement policies in developed regions also contribute significantly to market growth.

Looking ahead, the market is expected to benefit from continuous innovation in digital health technologies and remote monitoring solutions. The development of compact, wireless neurodiagnostic systems will enhance accessibility in emerging markets. Growing telemedicine adoption and personalized treatment approaches will further expand demand. As neurological disorders continue to rise globally, the need for accurate and efficient diagnostic and monitoring devices will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Electroencephalogram (EEG) Systems
• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Scanner
• Position Emission Tomography (PET) System
• Ultrasound Imaging Systems
• Others

By Indication

• Neurodegenerative Disease
• Epilepsy
• Stroke
• Others

By End-user

• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

COMPANIES PROFILED

• GE Healthcare, Neurosoft, Canon Medical Systems Corporation Canon Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co Ltd, Hologic Inc, Esaote SpA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Electroencephalogram (EEG) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Magnetic Resonance Imaging (MRI) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Computed Tomography (CT) Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Position Emission Tomography (PET) System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ultrasound Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Neurodegenerative Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Diagnostic Laboratories & Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Research Laboratories & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GE Healthcare
  • 9.2.2 Neurosoft
  • 9.2.3 Canon Medical Systems Corporation (Canon Inc.)
  • 9.2.4 Fujifilm Holding Corporation
  • 9.2.5 Koninklijke Philips N.V
  • 9.2.6 Siemens Healthineers AG
  • 9.2.7 Shimadzu Corporation
  • 9.2.8 United Imaging Healthcare Co. Ltd
  • 9.2.9 Hologic Inc
  • 9.2.10 Esaote SpA